Itron director Timothy M. Leyden granted 243 shares

Q: How many shares did ITRI director Timothy M. Leyden receive?

Leyden received a grant of 243 common shares on October 1, 2026. The grant reflects quarterly common-stock compensation for independent board members as part of their annual compensation for board service.

Q: How many ITRI shares did Timothy M. Leyden hold after the grant?

Leyden reported direct holdings of 16,496 shares after the transaction on October 1, 2026. He deferred receipt of 91 shares under Itron's Executive Deferred Compensation Plan.

After the award, Leyden reported 16,496 directly held shares; 91 shares were deferred under Itron's compensation plan.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Itron, Inc. (ITRI) director Timothy M. Leyden received a grant of 243 common shares on October 1, 2026, as part of quarterly compensation for board service. He deferred receipt of 91 shares under Itron's Executive Deferred Compensation Plan. His reported direct holdings after the grant were 16,496 shares.

Insider Trade Summary

Grant/Award: 243 shares

Grant/Award 1 txn

Insider LEYDEN TIMOTHY M

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock ^F1	243	$0.00	$0.00

Holdings After Transaction: Common Stock — 16,496 shares (Direct)

Footnotes (1)

F1. Reflects the grant of common stock independent members of Itron's board of directors receive quarterly as part of their annual compensation for board service. Mr. Leyden deferred receipt of 91 shares pursuant to Itron's Executive Deferred Compensation Plan.

Key Figures

Common-stock award: 243 shares Deferred receipt: 91 shares Direct holdings after transaction: 16,496 shares

3 metrics

Common-stock award 243 shares Granted October 1, 2026

Deferred receipt 91 shares Under Itron's Executive Deferred Compensation Plan

Direct holdings after transaction 16,496 shares After the October 1, 2026 transaction

Key Terms

Executive Deferred Compensation Plan

1 terms

Executive Deferred Compensation Plan financial

"deferred receipt of 91 shares pursuant to Itron's Executive Deferred Compensation Plan"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares did ITRI director Timothy M. Leyden receive?

Leyden received a grant of 243 common shares on October 1, 2026. The grant reflects quarterly common-stock compensation for independent board members as part of their annual compensation for board service.

How many ITRI shares did Timothy M. Leyden hold after the grant?

Leyden reported direct holdings of 16,496 shares after the transaction on October 1, 2026. He deferred receipt of 91 shares under Itron's Executive Deferred Compensation Plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 10/05/2026 - 12:51 PM Accepted by SEC EDGAR 10/05/2026 - 12:51 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LEYDEN TIMOTHY M

(Last)

(First)

(Middle)

2111 N. MOLTER ROAD

(Street)

LIBERTY LAKE

WASHINGTON

99019

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ITRON, INC. [ ITRI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	10/01/2026		A		243⁽¹⁾	A	$0	16,496	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Reflects the grant of common stock independent members of Itron's board of directors receive quarterly as part of their annual compensation for board service. Mr. Leyden deferred receipt of 91 shares pursuant to Itron's Executive Deferred Compensation Plan.

	/s/ Christopher E. Ware, attorney-in-fact	10/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR